Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factors

Osteosarcoma (OS) is a bone cancer exhibiting a 20% survival rate for metastatic patients, which motivates the development of new therapeutic options. Among the various new treatment approaches, modulation of autophagy is the subject of rising interest. In addition to its pro-survival role in establ...

Full description

Bibliographic Details
Main Authors: Olivier Camuzard, Marie Nollet, Sabine Santucci-Darmanin, Marie-Charlotte Trojani, Nadia Ben Abderrahman, Virginie Virolle, Fanny Burel-Vandenbos, Sophie Pagnotta, François Orange, Ewa Kolano-Merlin, Georges F. Carle, Valérie Pierrefite-Carle
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Autophagy Reports
Subjects:
Online Access:http://dx.doi.org/10.1080/27694127.2022.2112125

Similar Items